Symbiomix Acquired After Securing FDA Approval; The deal includes $150 million in cash, plus potential milestones

Published: 12/10/2017
Symbiomix Acquired After Securing FDA Approval; The deal includes $150 million in cash, plus potential milestones
Source: PEVC.DOWJONES.COM

Symbiomix Therapeutics LLC has been acquired by drug company Lupin following Food and Drug Administration approval of its lead treatment for gynecologic infection.

Read more
Related news
Comment